When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
NVSEF - Legend Biotech Seeks U.S. Capital For Pipeline Advance
Novartis Ag Basel Akt
Quick Take
Legend Biotech Corp. (LEGN) has filed to raise $100 million in an IPO of its ADSs representing ordinary shares, according to an F-1 registration statement.
Legend Biotech is spinning out from parent firm GenScript Biotech to pursue treatments in CAR T cell therapies for multiple myeloma.
LEGN has produced promising Phase 2 trial results for its lead candidate.
I’ll provide a final opinion when we learn more IPO details from management.
Company & Technology
Somerset, New Jersey-based Legend was founded within GenScript Biotech to advance a pipeline of drug treatment